Chemed Corporation
CHE · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7 | $7 | $9 | $8 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $7 | $7 | $9 | $8 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 1% | -4.4% | 1.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 28.9% | 29.8% | 33.5% | 36.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 16.3% | 14.2% | 17.3% | 21.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 10.3% | 8.5% | 11.1% | 14.1% |
| EPS Diluted | 4.46 | 3.57 | 4.86 | 6.02 |
| % Growth | 24.9% | -26.5% | -19.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |